Companies

West Pharmaceutical Services Inc

NYSE: WST
$432.83
▲ $29.19 (+7.23%) today
Markets open · 11:46am ET

24/7 Wall St. View

Price Prediction $496.34 +23.0% Our analysts’ 12-month view: target, optimistic case, and floor. WST price prediction → Earnings Beat +21.1% EPS vs. the estimate, revenue, and how the market reacted. WST earnings history →

WST at a Glance

Price
24/7 target
$496.34
Street target
$416.40
Earnings
Next report
Oct 29, 2026
Q3 2026 EPS
$2.66
vs. $2.20 est.
+21.1%

NYSE: WST

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. provides injectable containment and drug delivery solutions and services to pharmaceutical, biotech and CDMO customers. It reports two segments.

Proprietary Products (about 83% of Q3 2026 sales) has three product categories:
- HVP Components: high-value elastomer components such as stoppers and plungers, including Envision-inspected and washed products.
- HVP Delivery Devices: administration systems and Daikyo Crystal Zenith-based containers.
- Standard Products: basic primary containment components.

Proprietary Products serves Biologics, Pharma and Generics customers. Key demand drivers are GLP-1 therapies (about 21% of sales) and regulatory-driven upgrades to higher-value components, such as EU Annex 1.

West Vantage (about 17% of sales) provides contract manufacturing of drug delivery and medical devices, including GLP-1-related work.

The company has over 10,000 team members across 50 sites, including 26 manufacturing facilities, and delivers over 41 billion components and devices annually. It generated $3.07 billion in net sales in fiscal 2025. In 2026 it divested its SmartDose 3.5mL On-Body Delivery System and associated facilities to AbbVie. It is listed on the NYSE (WST) and is included in the S&P 500. Updated

Revenue by Segment · Q3 2026
  1. Proprietary Products83%
  2. West Vantage17%

Latest Activity

WSTWest Pharmaceutical Services
Q3 2026
EPS
$2.66
est $2.20+21.1%
Revenue
$875M
est $827M+5.8%

Management raised full-year EPS guidance to $9.38 to $9.48 as high-value product components grew 20.3% organically on GLP-1 and biologics demand.

Quarterly EPS — reported vs estimate
Read more

WST Coverage

8:30am ET
Investing

3 Dividend Aristocrats Wall Street Says Can Soar 48% in 2025

Dividend growth investing focuses on acquiring stocks that consistently increase their dividends, providing investors with a reliable, inflation-beating income stream and potential capital appreciation. This strategy prioritizes companies with strong fundamentals, stable…

ALB NUE WST
Rich Duprey
Load More

Frequently Asked Questions

What does West Pharmaceutical Services do?

West Pharmaceutical Services, Inc. provides injectable containment and drug delivery solutions and services to pharmaceutical, biotech and CDMO customers. It reports two segments.

What is the WST stock price target?

24/7 Wall St.'s 12-month price target for WST is $496.34, rated Buy. The Wall Street consensus target is $416.40. WST price prediction →